
| Pair Name | Ginsenoside Rb1, Cisplatin | ||
| Phytochemical Name | Ginsenoside Rb1 (PubChem CID: 9898279 ) | ||
| Anticancer drug Name | Cisplatin (PubChem CID: 5702198 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Ginsenoside Rb1, Cisplatin | |||
| Disease Info | [ICD-11: 2C25.Z] | Lung cancer | Investigative | |
| Biological Phenomena | Inhibition-->Two efflux pumps | |||
| Gene Regulation | Down-regulation | Expression | GLI2 | hsa2736 |
| Down-regulation | Expression | ABCB1 | hsa5243 | |
| Down-regulation | Expression | PTCH1 | hsa5727 | |
| Down-regulation | Expression | SHH | hsa6469 | |
| In Vitro Model | A549/DDP | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_C0W4 |
| In Vivo Model | 6×10⁶ A549 or A549/DDP cells were subcutaneously injected into BALB/c-nu mice to establish the model of tumor-bearing mice. | |||
| Result | Ginsenoside Rb1 for overcoming cisplatin-insensitivity of A549/DDP cells in vitro and vivo through the dual-inhibition on two efflux pumps of ABCB1 and PTCH1 | |||
| No. | Title | Href |
|---|---|---|
| 1 | Ginsenoside Rb1 for overcoming cisplatin-insensitivity of A549/DDP cells in vitro and vivo through the dual-inhibition on two efflux pumps of ABCB1 and PTCH1. Phytomedicine. 2023 Jul;115:154776. doi: 10.1016/j.phymed.2023.154776. | Click |